Back To Search Results

Tanner Stages

Editor: Brooke R. Bokor Updated: 12/11/2022 9:17:26 PM

Introduction

 Puberty is a time of rapid and complex changes involving overlapping components: hormonal, physical, and cognitive. Tanner Staging, also known as Sexual Maturity Rating (SMR), is an objective classification system that providers use to document and track the development and sequence of secondary sex characteristics of children during puberty. It was developed by Marshall and Tanner while conducting a longitudinal study from the 1940s to the 1960s in England. Based on observational data, they developed separate scales for the development of external genitalia: phallus, scrotum, and testes volume in males, breasts in females, and pubic hair in both males and females.

The physical changes of puberty require a concerted effort from many organs; these changes are initiated by activating the hypothalamic-pituitary-gonadal (HPG) axis (gonads refer to ovaries in females and testes in males). The first hormonal change in puberty is the pulsatile release of GnRH triggered by disinhibition of the hypothalamic-pituitary-gonadal (HPG) axis. Although the cause of this disinhibition is largely unknown, the subsequent release of GnRH stimulates the pulsatile release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH act on specific gonadal cells to stimulate the release of androgens, estrogens, and gametogenesis. LH stimulates the theca cells in the ovary to produce estrogen precursors and the Leydig cells of the testes to produce testosterone. On the other hand, FSH works on the ovarian follicle to convert the thecal estrogen precursors to estrogen and on the Sertoli cells in the seminiferous tubules of the testes to help create sperm. This complex process leads to increased estrogen and testosterone production that then facilitates the development of breasts and the formation of adult male genitalia.[1][2][3]

The adrenal glands also contribute to the formation of secondary sex characteristics, particularly pubarche, which is the development of pubic and axillary hair. Although adrenal maturation often coincides with HPG axis maturation, it is important to note that these processes occur independently and that pubarche itself is not the best indicator of pubertal development.[4]

Function

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Function

The normal onset and sequence of physical maturation vary greatly based on sex, race and ethnicity, and environmental factors. Tanner Stages are utilized in pediatric and adolescent practice to counsel patients about the timing of anticipated body changes, perform appropriate medical screenings, and monitor for deviations in normal timing and sequence of physical signs of puberty that may represent physiologic problems. Changes associated with but not directly measured by Tanner staging include bone growth and fusion, body composition and linear growth, and hematocrit values. Rather than chronological age, Tanner Staging should be used in assessing pubertal development. Clinical examples of use include delivering timely anticipatory guidance on menstrual hygiene needs (menarche occurs about 2 years post-thelarche/tanner 2 breasts) or targeting scoliosis exams at well-visits before and during peak height velocity (Tanner 2 to 3, depending on sex).[4][5][6]

In females, the normal onset of puberty ranges from 8 to 13 years old, averaging 10 years in White Americans and 8.9 years in African Americans. Puberty in females begins with the development of breast buds under the areola, also known as thelarche, and represents entry into Tanner Stage 2. As puberty progresses, the glandular tissue of the breast increases in size and changes in contour. In females, thelarche is followed in 1 to 1.5 years by the onset of sexual hair (pubic and axillary), known as pubarche. Menarche, the onset of menses, arrives on average at age 12.5 years, regardless of ethnicity, following thelarche by 2.5 years (range 0.5 to 3 years). Between Tanner Stage 2 and 3 breast development, females experience peak height velocity. African-American females have closer to 3 years between their thelarche and menarche, accounting for greater height potential. 

The onset of puberty in males ranges from 9 to 14 years of age. The first secondary sexual characteristic visible is gonadarche when the testicular volume reaches greater than or equal to 4 mL (or long axis greater than or equal to 2.5 cm) and enters Tanner stage 2. During Tanner Stage 3 genital development, males undergo peak height velocity. Spermarche, the counterpart of menarche in females, is sperm development in males and typically occurs during genital Tanner Stage 4. 

Issues of Concern

Pubertal development generally follows a predictable onset, sequence, and velocity pattern. However, population norms are published to help clinicians determine which adolescents fall outside two standard deviations of the mean and require further investigation. Precocious puberty is defined as the onset of Tanner 2 secondary sexual characteristics before age 8 years in females or age 9 years in males if the continued progression of pubertal development occurs soon after. Delayed puberty should be considered if females have not reached Tanner 2 thelarche by age 13 or if males have not reached Tanner 2 gonadarche by age 14. Primary amenorrhea is defined as a failure to start menses within 3 years of Tanner Stage 2 (thelarche) or by age 15 years. It is important to note that some males temporarily develop glandular breast tissue (pubertal gynecomastia) between genital tanner stages 3 and 4, which may be emotionally troubling but not physically harmful. Abnormalities may be caused by idiopathic conditions, nutritional deficiencies,[7][8] HPG axis variations, or neoplastic and genetic disorders. Describing these disorders is outside the scope of this topic.

Clinical Significance

Below are the Tanner Stages described in detail for clinical reference. Tanner Stage 1 corresponds to the pre-pubertal form for all three development sites, with progression to Tanner Stage 5, the final adult form. Breast and genital staging and other physical markers of puberty, such as height velocity, should be relied on more than pubic hair staging to assess pubertal development because of the independent maturation of the adrenal axis. 

Pubic Hair Scale (both males and females)

  • Stage 1: No hair
  • Stage 2: Downy hair
  • Stage 3: Scant terminal hair
  • Stage 4: Terminal hair that fills the entire triangle overlying the pubic region
  • Stage 5: Terminal hair that extends beyond the inguinal crease onto the thigh

Female Breast Development Scale

  • Stage 1: No glandular breast tissue palpable 
  • Stage 2: Breast bud palpable under the areola (1st pubertal sign in females)
  • Stage 3: Breast tissue palpable outside areola; no areolar development
  • Stage 4: Areola elevated above the contour of the breast, forming a “double scoop” appearance
  • Stage 5: The areolar mound recedes into a single breast contour with areolar hyperpigmentation, papillae development, and nipple protrusion

Male External Genitalia Scale

  • Stage 1: Testicular volume < 4 ml or long axis < 2.5 cm
  • Stage 2: 4 ml-8 ml (or 2.5 to 3.3 cm long), 1st pubertal sign in males
  • Stage 3: 9 ml-12 ml (or 3.4 to 4.0 cm long)
  • Stage 4: 15-20 ml (or 4.1 to 4.5 cm long)
  • Stage 5: > 20 ml (or > 4.5 cm long)

Enhancing Healthcare Team Outcomes

An interprofessional team of clinicians and nurses should provide the screening evaluation of pediatric patients. All healthcare workers should know the Tanner stages, including nurses, nurse practitioners, physician assistants, and physicians who evaluate pediatric patients. This allows them to know if sexual development is normal or abnormal; the earlier the referral to the appropriate specialist, the better the outcomes.[6]

References


[1]

Dir AL, Hummer TA, Aalsma MC, Hulvershorn LA. Pubertal influences on neural activation during risky decision-making in youth with ADHD and disruptive behavior disorders. Developmental cognitive neuroscience. 2019 Apr:36():100634. doi: 10.1016/j.dcn.2019.100634. Epub 2019 Mar 7     [PubMed PMID: 30889545]


[2]

Wu Y, Sánchez BN, Goodrich JM, Dolinoy DC, Cantoral A, Mercado-Garcia A, Ruiz-Narváez EA, Téllez-Rojo MM, Peterson KE. Dietary exposures, epigenetics and pubertal tempo. Environmental epigenetics. 2019 Jan:5(1):dvz002. doi: 10.1093/eep/dvz002. Epub 2019 Mar 7     [PubMed PMID: 30863553]


[3]

Subramanian S, Viswanathan VK. Bone Age. StatPearls. 2024 Jan:():     [PubMed PMID: 30725736]


[4]

De Sanctis V,Elhakim IZ,Soliman AT,Elsedfy H,Elalaily R,Millimaggi G, Methods for Rating Sexual Development in Girls. Pediatric endocrinology reviews : PER. 2016 Sep;     [PubMed PMID: 28508614]


[5]

Sotos JF, Tokar NJ. Appraisal of testicular volumes: volumes matching ultrasound values referenced to stages of genital development. International journal of pediatric endocrinology. 2017:2017():7. doi: 10.1186/s13633-017-0046-x. Epub 2017 Jul 17     [PubMed PMID: 28725240]


[6]

Berenbaum SA, Beltz AM, Corley R. The importance of puberty for adolescent development: conceptualization and measurement. Advances in child development and behavior. 2015:48():53-92. doi: 10.1016/bs.acdb.2014.11.002. Epub 2015 Jan 22     [PubMed PMID: 25735941]

Level 3 (low-level) evidence

[7]

Zemel B. Bone mineral accretion and its relationship to growth, sexual maturation and body composition during childhood and adolescence. World review of nutrition and dietetics. 2013:106():39-45. doi: 10.1159/000342601. Epub 2013 Feb 11     [PubMed PMID: 23428679]


[8]

Den Hond E,Schoeters G, Endocrine disrupters and human puberty. International journal of andrology. 2006 Feb;     [PubMed PMID: 16466548]

Level 2 (mid-level) evidence